Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases

Errors in protein, folding, may result in premature clearance of structurally aberrant proteins, or in the, accumulation of toxic misfolded species or protein aggregates. These pathological events lead to a large range of conditions known as Conformational diseases. Several research groups have presented possible therapeutic solutions, for their treatment by developing,novel compounds, known as: pharmacological chaperones.. These cell-permeable molecules selectively provide a molecular scaffold around which misfolded proteins can recover their native folding and; thus, their 'biological activities. Here, we review therapeutic Strategies, clinical potentials, and cost-benefit impacts of several classes of pharmacological chaperones,for the:treatment of a, series of conformational diseases.